The Latest: Pfizer modifies protocol for virus vaccine study
|
October 12, 2020 3:27 PM
NEW YORK — Drugmaker Pfizer has again modified the protocol for its late-stage study of its vaccine against the new coronavirus, this time to include more young participants.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
